Balyasny Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1M Sell
91,100
-14,400
-14% -$5.13M 0.04% 502
2025
Q4
$34.5M Buy
105,500
+48,100
+84% +$15.3M 0.04% 477
2025
Q3
$16.2M Buy
57,400
+23,800
+71% +$6.9M 0.02% 810
2025
Q2
$9.38M Buy
33,600
+3,800
+13% +$1.08M 0.01% 997
2025
Q1
$9.28M Buy
29,800
+11,900
+66% +$3.51M 0.02% 952
2024
Q4
$4.67M Sell
17,900
-13,100
-42% -$3.89M 0.01% 1319
2024
Q3
$9.99M Sell
31,000
-6,500
-17% -$2.13M 0.02% 955
2024
Q2
$11.7M Buy
+37,500
New +$11M 0.02% 812
2024
Q1
Sell
-8,000
Closed -$2.3M 2579
2023
Q4
$2.3M Buy
+8,000
New +$2.18M ﹤0.01% 1408
2023
Q1
Sell
-17,300
Closed -$4.54M 2610
2022
Q4
$4.54M Hold
17,300
0.01% 1074
2022
Q3
$3.9M Buy
17,300
+7,600
+78% +$1.84M 0.01% 1145
2022
Q2
$2.36M Buy
9,700
+7,100
+273% +$1.74M 0.01% 1325
2022
Q1
$629K Buy
+2,600
New +$597K ﹤0.01% 1759
2021
Q3
Sell
-6,100
Closed -$1.49M 1905
2021
Q2
$1.49M Buy
+6,100
New +$1.5M 0.01% 1109
2020
Q4
Sell
-60,000
Closed -$15.3M 1296
2020
Q3
$15.3M Buy
60,000
+20,000
+50% +$4.95M 0.11% 266
2020
Q2
$9.43M Buy
+40,000
New +$9.13M 0.08% 350
2019
Q2
Sell
-72,000
Closed -$13.7M 1452
2019
Q1
$13.7M Sell
72,000
-36,000
-33% -$6.87M 0.09% 316
2018
Q4
$21M Buy
108,000
+55,500
+106% +$10.8M 0.15% 189
2018
Q3
$10.7M Buy
+52,500
New +$10.3M 0.05% 473
2017
Q3
Sell
-175,000
Closed -$30.1M 1856
2017
Q2
$30.1M Buy
+175,000
New +$28.5M 0.12% 219
2017
Q1
Sell
-45,000
Closed -$6.58M 1570
2016
Q4
$6.58M Buy
+45,000
New +$6.77M 0.04% 617

Other funds holding AMGN

Balyasny Asset Management's AMGN Position: Q1 2026 in Review

Balyasny Asset Management reduced its Amgen (AMGN) stake by 42% in Q1 2026, selling an estimated $2.03M and leaving 7,980 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Balyasny Asset Management first reported a position in AMGN in Q3 2014 and has held it in 35 quarters since. The position peaked at $96.1M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Balyasny Asset Management held 7,980 shares of Amgen worth $2.81M as of Q1 2026.
  • Balyasny Asset Management sold 5,688 Amgen shares in Q1 2026, an estimated $2.03M.
  • Amgen made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1628 holding.
  • Balyasny Asset Management first reported a position in Amgen in Q3 2014 and has held it in 35 quarters since.
  • Balyasny Asset Management's Amgen position peaked at $96.1M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.